Road 2 Web Summit (R2WS) has elected Ophiomics to be one of the selected portuguese Startups to have free access to this year’s edition of Web Summit. Along with this benefit, Ophiomics will also have the opportunity to participate in an intensive training program centred on key content for the company. Exciting times for Ophiomics!
Ophiomics was short listed as one of the top 25 scale ups in Portugal 2020! Thank you BGI for your efforts in putting together the Scale Up Report every year and for the recognition of our work From their site: “Scaleup Portugal was born in 2017, after BGI was asked who were the best Portuguese startups by
Great News! Ophiomics just won the Everis Award – Portugal, and is now in the final stage of the competition to the International Everis Award in November. The Everis Award Portugal, in addition to the always so important monetary component, includes coaching by experts from the Everis network. Thank you Everis Foundation. You can read the
Ophiomics is growing! We are very happy to have onboard new team members that bring expertise in strategic fields. Our team will be focused on developing HepatoPredict – A decision tool for Liver Transplantation based on molecular signature, that has recently been awarded funding by the program EIC Accelerator. Welcome!SaraDianaMariaAndréFilipa
We have moved to a new location at Lispolis (Lisbon’s Technological Park), a strategic location for technological and innovative companies in Lisbon. We have a new home at the Center of Incubation and Development with a dedicated office space and a custom-built and newly equipped laboratory. You can find us at:
As part of its development of new diagnostic and prognostic solutions for liver cancer, Ophiomics conducts research using data from patients, and conducts retrospective and prospective clinical studies. These all raise multiple ethics issues. We are happy to announce that Prof. Ana Sofia Carvalho is joining our Advisory Board as our Ethics Mentor. Prof. Carvalho
Ophiomics wins EIC accelerator funding in its pilot scheme. This hybrid funding scheme that includes a grant together with investment from the European Investment Bank, will permit Ophiomics to take HepatoPredcit to market and make a difference in selecting the right patients cancer for liver transplantation.
Health Europa, a publisher of digital content on Health issue sin Europe and beyond, published a feature about Ophiomics and HepatoPredict in its Health Europa Quarterly Issue.